Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Other neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 82Leukemia, Myeloid, Acute 63Leukemia, Myelomonocytic, Chronic 31Leukemia 21Myeloproliferative Disorders 15Primary Myelofibrosis 9Thrombocythemia, Essential 7Polycythemia Vera 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Blast Crisis 7Myelodysplastic-Myeloproliferative Diseases 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Anemia, Refractory 4Leukemia, Monocytic, Acute 3Congenital Abnormalities 3Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Cyclophosphamide 72fludarabine phosphate 69Peripheral Blood Stem Cell Transplantation 58Mycophenolic Acid 56Whole-Body Irradiation 44Tacrolimus 44Cyclosporine 43Antilymphocyte Serum 39Busulfan 37Filgrastim 28Radiotherapy 27Methotrexate 26Cord Blood Stem Cell Transplantation 24Melphalan 20Methylprednisolone 19fludarabine 13Flow Cytometry 11Etoposide 11Sirolimus 10Therapeutics 9Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 7Cytarabine 7Cyclosporins 7Alemtuzumab 7thymoglobulin 6sargramostim 6Polymerase Chain Reaction 6Rituximab 5Allopurinol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Decitabine × Myeloid × Clear all
NCT00002980 2013-02-15

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Completed
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡